Efalizumab-associated papular psoriasis: An adverse reaction to efalizumab in three cases

Journal of Dermatological Treatment

Volumn 20, Issue 1, 2009, Pages 61-62

  Antonucci, Angela ^a   Bardazzi, Federico ^a   Balestri, Riccardo ^a   Patrizi, Annalisa ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Efalizumab; Neutrophilic dermatoses; Papular psoriasis

Indexed keywords

CORTICOSTEROID; EFALIZUMAB;

ACANTHOSIS; ADULT; ARTICLE; AXILLA; CASE REPORT; ERYTHEMA; HISTOPATHOLOGY; HUMAN; INGUINAL REGION; LABORATORY TEST; LOCAL SKIN REACTION; LYMPHOCYTOSIS; MALE; NECK; PAPULAR PSORIASIS; PAPULAR RASH; PARAKERATOSIS; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; SKIN PRURITUS; TREATMENT DURATION; TRUNK;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, MONOCLONAL; AXILLA; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PSORIASIS; RISK ASSESSMENT; SAMPLING STUDIES;

EID: 61649107176     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630802206652     Document Type: Article

References (6)

1. Akmal SH, Dagmar S, Hans-Uwe S, Lasse RB, Nikhil Y. Efalizumab-associated papular psoriasis. Arch Dermatol. 2007;143:900-6.
2. Shear NH, Langley RG, Ho V. Efalizumab, a reversible T-cell modulator for psoriasis. J Cutan Med Surg. 2006;9 suppl 1:4-9.
3. Antoniou C, Stefanaki I, Stratigos A, Avgerinou G, Stravropoulos P, Potouridou I, et al. The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital. Br J Dermatol. 2007;156 suppl 2:12-16.
4. Menter A, Leonardo CL, Sterry W, Bos JD, Papp KA. Long-term management of plaque psoriasis with continuous efalizumab therapy. J Am Acad Dermatol. 2006;54:S181-8.
5. Hamilton TK. Clinical considerations of efalizumab therapy in patients with psoriasis. Semin Cutan Med Surg. 2005;24:19-27.
6. Lowes MA, Chamian F, Abello MV, Leonardi C, Dummer W, Papp K, et al. Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: A case series. BMC Dermatol. 2007;7:2.